{
    "title": "A bill to prevent health care facility-acquired infections.",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``MRSA Infection Prevention and \nPatient Protection Act''.\n\nSEC. 2. DEFINITIONS.\n\n    In this Act:\n            (1) Acute care hospital.--The term ``acute care hospital'' \n        means a hospital that maintains and operates an emergency room \n        (including a trauma or burn center), surgical unit, birthing \n        facility, and such other unit that is highly susceptible to \n        acquiring or transmitting infections, as determined by the \n        Secretary through regulations.\n            (2) Hospital.--The term ``hospital'' has the meaning given \n        such term in section 1861(e) of the Social Security Act (42 \n        U.S.C. 1395x(e)) and includes critical access hospitals (as \n        defined in section 1861(mm) of such Act) and other entities \n        determined to be hospitals by the Secretary.\n            (3) MRSA.--The term ``MRSA'' means Methicillin-resistant \n        Staphylococcus aureus.\n            (4) Other infection.--The term ``other infection'' means an \n        infection that the Secretary, after consultation with the \n        Director of the Centers for Disease Control and Prevention and \n        other public health officials, as appropriate, and after public \n        hearing, determines to be, or to have the potential to become, \n        a serious source of morbidity and mortality in health care \n        facilities.\n            (5) Secretary.--The term ``Secretary'' means the Secretary \n        of Health and Human Services.\n\nSEC. 3. HOSPITAL INFECTION PREVENTION PROGRAMS.\n\n    (a) Regulations.--\n            (1) In general.--Not later than 150 days after the date of \n        enactment of this Act, the Secretary, in consultation with the \n        Director of the Centers for Disease Control and Prevention and \n        such independent experts as the Secretary determines \n        appropriate, shall promulgate regulations that--\n                    (A) provide a list of best practices for preventing \n                MRSA infections and such other antibiotic resistant \n                pathogens as the Secretary determines appropriate;\n                    (B) define the term ``high risk hospital \n                departments'' for purposes of applying the best \n                practices provided for under subparagraph (A), which \n                may include surgical, burn, neonatal, and such other \n                departments as the Secretary determines;\n                    (C) define the term ``serious source of morbidity \n                and mortality'' in quantitative terms for purposes of \n                determining the applicability of this Act to other \n                infections, except that such definition shall not \n                require morbidity and mortality rates of more than 1 \n                percent of the estimated patient population at risk for \n                a particular infection in order for an infection to \n                qualify as a serious source of morbidity and mortality; \n                and\n                    (D) provide screening, recordkeeping, and other \n                requirements as they relate to reductions in MRSA \n                infections.\n            (2) Consistency.--The regulations promulgated under this \n        subsection shall be consistent with the requirements of this \n        Act.\n            (3) Effective date.--The regulations promulgated under \n        paragraph (1) shall take effect on the date that is 30 days \n        after the date on which such regulations are published in the \n        Federal Register, but in no case later than 180 days after the \n        date of enactment of this Act.\n    (b) Screening Requirements.--\n            (1) In general.--Not later than 180 days after the date of \n        enactment of this Act, each acute care hospital shall screen \n        each patient entering an intensive care unit or other high risk \n        hospital department (as defined in the regulations promulgated \n        under subsection (a)(1)(B)).\n            (2) Extension of requirements.--\n                    (A) In general.--The Secretary, in consultation \n                with the Director of the Centers for Disease Control \n                and Prevention, shall establish a process and a \n                timetable for extending the screening requirements of \n                paragraph (1) to all patients admitted to all \n                hospitals.\n                    (B) Requirements fully applied.--The timetable \n                established under subparagraph (A), shall require that \n                all patients be covered by the screening requirements \n                under paragraph (1) by not later than January 1, 2014.\n                    (C) Waiver.--The Secretary may waive the \n                requirements of this paragraph if the Secretary \n                determines, at the recommendation of the Director of \n                the Centers for Disease Control and Prevention and \n                after public hearing, that the rate of MRSA infections \n                or other infections has declined to a level at which \n                further screening is no longer needed.\n            (3) Medicare.--\n                    (A) Requirement.--\n                            (i) In general.--Section 1866(a)(1) of the \n                        Social Security Act (42 U.S.C. 1395cc(a)(1)) is \n                        amended--\n                                    (I) by striking ``and'' at the end \n                                of subparagraph (U);\n                                    (II) by striking the period at the \n                                end of subparagraph (V) and inserting \n                                ``, and''; and\n                                    (III) by inserting after \n                                subparagraph (V) the following:\n            ``(W) in the case of an acute care hospital (as defined in \n        section 2(1) of the MRSA Infection Prevention and Patient \n        Protection Act), to comply with the screening requirements \n        described in section 3 of such Act.''.\n                            (ii) Effective date.--The amendments made \n                        by clause (i) shall apply to agreements entered \n                        into or renewed on or after the date that is \n                        180 days after the enactment of this Act.\n                    (B) Medicare payment adjustments.--Not later than \n                January 1, 2011, the Secretary shall submit to the \n                appropriate committees of Congress, a report on whether \n                payment adjustments should be made under title XVIII of \n                the Social Security Act (42 U.S.C. 1395 et seq.) to \n                assist certain hospitals in defraying the cost of \n                screening for, and the subsequent treatment of, MRSA \n                infections (or other infections). In preparing such \n                report, the Secretary shall give special consideration \n                to the needs of rural, critical access, sole community, \n                and Medicare dependent hospitals, and disproportionate \n                share hospitals and other hospitals with a \n                disproportionate share of immune compromised patients.\n    (c) Best Practices.--In addition to any other best practices \ncontained in the regulations promulgated under subsection (a)(1)(A), \neach hospital shall comply with the following:\n            (1) A hospital shall require contact (barrier) precautions, \n        as determined by the Secretary, be taken when treating patients \n        who test positive for MRSA colonization (as defined by the \n        Centers for Disease Control and Prevention).\n            (2) Where possible, a hospital shall--\n                    (A)(i) isolate, with the same staffing ratio per \n                bed as in the non-isolated beds of the hospital, or \n                cohort patients colonized or infected with MRSA; or\n                            (ii) notify any patients with whom the \n                        infected patient may room that such patient has \n                        tested positive for MRSA;\n                    (B) control and monitor the movements of such \n                patients within the hospital; and\n                    (C) take whatever steps are needed to stop the \n                transmission of MRSA bacteria to patients who did not \n                come into the hospital infected or colonized with such \n                bacteria.\n        The Secretary may suspend the application of this paragraph in \n        the case of an emergency.\n            (3) All patients who test positive for MRSA shall be \n        informed of the results. All MRSA test results shall be noted \n        in the patient's medical record.\n            (4) Each hospital shall, by January 1, 2010, adopt a policy \n        requiring any patient who has a MRSA infection to receive oral \n        and written instructions regarding aftercare and precautions to \n        prevent the spread of the infection to others.\n            (5) Patients being discharged from intensive care units \n        shall be tested again for MRSA, and those patients testing \n        positive shall be informed of their status, and that status \n        shall be noted in the patient's medical records in case of \n        readmittance to a hospital.\n            (6) A hospital shall educate its staff concerning modes of \n        transmission of MRSA, use of protective equipment, disinfection \n        policies and procedures, and other preventive measures.\n            (7) A hospital shall provide other interventions, as the \n        Secretary determines to be necessary, for control of MRSA \n        infection.\n    (d) Reporting.--\n            (1) In general.--Not later than January 1, 2011, each \n        hospital shall, using the National Healthcare Safety Network of \n        the Centers for Disease Control and Prevention, report \n        hospital-acquired MRSA and other infections that occur in the \n        hospital facility. The Secretary shall develop a process for \n        the risk adjustment of such reports by hospitals.\n            (2) Publication.--The Secretary shall develop a system for \n        the publication of hospital-specific infection rates, including \n        the rate of MRSA infections.\n    (e) Non-Hospital Medicare Providers.--\n            (1) MRSA infection reporting.--The Secretary, using the \n        MRSA infection and other infection information identified under \n        subsection (b) and such other billing and coding information as \n        necessary, shall promulgate regulations to--\n                    (A) define the term ``infected transferred \n                patient'', to describe a patient who, after discharge \n                from, or treatment at, a non-hospital Medicare \n                provider, is admitted to the hospital with MRSA \n                infection (or other infection);\n                    (B) establish a system for identifying infected \n                transferred patients;\n                    (C) establish a system to promptly inform any \n                facility that has transferred an infected patient; and\n                    (D) establish requirements that any non-hospital \n                Medicare provider that treats an infected transferred \n                patient described under subparagraph (A) and that \n                cannot provide a reasonable explanation that the \n                infection was not acquired in the facility, submit to \n                the Secretary an action plan describing how such \n                provider plans to reduce the incidence of such \n                infections.\n            (2) Assistance.--The Secretary shall promulgate regulations \n        to develop a program to provide technical assistance and \n        educational materials to non-hospital Medicare providers \n        described in paragraph (1)(A) in order to assist in preventing \n        subsequent MRSA infections.\n            (3) Publication of certain information.--If a non-hospital \n        Medicare provider identified using the system established under \n        paragraph (1) fails to take steps, as required by the \n        regulations promulgated under subparagraph (1)(D), to combat \n        MRSA infections, the Secretary shall publish the name of the \n        provider and the number of MRSA infections from such provider \n        in the previous year.\n    (f) Assistance.--\n            (1) In general.--To provide for the rapid implementation of \n        MRSA screening programs and initiatives through the \n        installation of certified MRSA screening equipment and the \n        provision of necessary support services, a hospital may submit \n        an application to the Secretary for a 1-year increase in the \n        amount of the capital-related costs payment made to the \n        hospital under the prospective payment system under section \n        1886(g) of the Social Security Act (42 U.S.C. 1395ww(g)). The \n        Secretary shall approve all requests that the Secretary \n        determines are reasonable and necessary.\n            (2) Repayment.--A hospital that receives an increase under \n        paragraph (1) shall, not later than 4 years after the date of \n        receipt of such increase, reimburse the Secretary for the costs \n        of such increase. Such costs shall include the accrual of \n        interest at the rate payable for Federal Treasury notes. Such \n        reimbursement may be in the form of reduced capital-related \n        costs payments to the hospital under the system described in \n        paragraph (1) for the years following the year in which the \n        increase was received.\n            (3) Certification system.--Not later than 180 days after \n        the date of enactment of this Act, the Secretary shall \n        promulgate regulations for the development of a system to \n        certify appropriate MRSA screening and support services for \n        purposes of this subsection.\n\nSEC. 4. MRSA TESTING PILOT PROGRAM.\n\n    (a) In General.--The Director of the Centers for Disease Control \nand Prevention (referred to in this section as the ``Director'') shall \naward a grant to 1 collaborative project involving an eligible hospital \nand qualified testing corporation on a competitive basis to carry out a \npilot program designed to develop a rapid, cost-effective method for \ntesting for MRSA using the polymerase chain reaction (referred to in \nthis section as ``PCR'') or other molecular testing methods.\n    (b) Purpose.--The pilot program described in subsection (a) shall \nbe designed to--\n            (1) develop a low-cost, nationally adoptable PCR-based \n        analytical system for timely MRSA testing and results;\n            (2) develop the system described in paragraph (1) so that \n        it is affordable to hospitals, thereby enabling compliance with \n        mandated MRSA testing requirements;\n            (3) develop a system for centralized reporting of results \n        receiving through such testing to appropriate governmental \n        agencies for the purpose of disease reporting and surveillance; \n        and\n            (4) develop a technology platform that may be extended to \n        other infections that the Director identifies as priorities for \n        detection, treatment, and surveillance.\n    (c) Eligibility.--The Secretary shall establish requirements \nregarding eligibility to receive a grant under this section, which \nshall include the following requirements:\n            (1) The collaborate project shall be between a nonprofit \n        hospital organized for charitable purposes under section \n        501(c)(3) of the Internal Revenue Code of 1986 and a qualified \n        testing corporation.\n            (2) The hospital shall serve as the beta test site for any \n        MRSA screening methods developed through the pilot program."
}